본문으로 건너뛰기
← 뒤로

Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma: a retrospective study in regions with a high prevalence of Helicobacter pylori infection.

1/5 보강
BMC gastroenterology 📖 저널 OA 97% 2021: 1/1 OA 2024: 14/14 OA 2025: 121/121 OA 2026: 58/64 OA 2021~2026 2026 Vol.26(1) OA
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
398 patients were included, with a mean age at diagnosis of 55.
I · Intervention 중재 / 시술
eradication therapy (98
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Accurate staging at diagnosis is essential for optimal management, as disease stage and the presence of lymphadenopathy are key predictors of relapse. [SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12876-026-04699-4.

Kim JW, Yeom DH, Park SY, Seo SY, You HS, You GR

📝 환자 설명용 한 줄

[BACKGROUND] This study aims to investigate the treatment outcomes and identify risk factors influencing complete remission (CR) and relapse in patients with gastric MALT lymphoma across different tre

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 95% CI 1.0–5.5

이 논문을 인용하기

↓ .bib ↓ .ris
APA Kim JW, Yeom DH, et al. (2026). Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma: a retrospective study in regions with a high prevalence of Helicobacter pylori infection.. BMC gastroenterology, 26(1). https://doi.org/10.1186/s12876-026-04699-4
MLA Kim JW, et al.. "Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma: a retrospective study in regions with a high prevalence of Helicobacter pylori infection.." BMC gastroenterology, vol. 26, no. 1, 2026.
PMID 41776408 ↗

Abstract

[BACKGROUND] This study aims to investigate the treatment outcomes and identify risk factors influencing complete remission (CR) and relapse in patients with gastric MALT lymphoma across different treatment modalities.

[METHODS] Three-hundred and ninety-eight patients with gastric MALT lymphoma were followed up for at least 48 weeks over 15 years in five tertiary hospitals in regions with high prevalence of () infection. A retrospective review was performed using medical records.

[RESULTS] A total of 398 patients were included, with a mean age at diagnosis of 55.5 ± 12.2 years and 176 (44.2%) were male. infection was identified in 293 patients (73.6%), and 363 (91.2%) were diagnosed with stage IE. Significant differences in age, sex, and stage at diagnosis were observed between -positive (HPP) and negative groups (HPN, all  < 0.05). In the HPP group, most patients underwent eradication therapy (98.9%), whereas 77.3% of HPN patients received eradication therapy, often combined with radiotherapy or chemotherapy. CR rate was 97.0%, with 98.3% in HPP and 93.3% in HPN ( = 0.018). During a median follow-up of 179 weeks, relapse occurred in 8.3% of patients, with 7.9% in HPP and 10.2% in HPN, respectively. Non-IE Modified Ann Arbor Stage (HR, 2.4; 95% CI, 1.0–5.5;  = 0.044), presence of lymphadenopathy (HR, 1.9; 95% CI, 1.2–3.1;  = 0.010), and lesions in multiple locations (HR, 2.1; 95% CI, 1.0 ~ 4.2;  = 0.037) at diagnosis correlated with a higher cumulative incidence of relapse (CIR). Multivariate Cox regression analysis showed that Non-IE Modified Ann Arbor Stage (aHR, 1.9; 95% CI, 1.2‒2.9;  = 0.004) and presence of lymphadenopathy (aHR, 1.5; 95% CI, 1.0‒2.3;  = 0.037) remained significantly correlated with higher CIR.

[CONCLUSIONS] Patients with gastric MALT lymphoma generally have a favorable prognosis, and eradication can lead to CR, even in -negative MALT lymphoma cases. Accurate staging at diagnosis is essential for optimal management, as disease stage and the presence of lymphadenopathy are key predictors of relapse.

[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12876-026-04699-4.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기